TG Therapeutics, Inc. (TGTX)

30.62 -0.11 (-0.36%) USD  |  NASDAQ  |  Dec 24, 12:20
More

TG Therapeutics SG&A Expense (TTM): 208.25M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Karyopharm Therapeutics, Inc. 109.63M
Axsome Therapeutics, Inc. 514.57M
Krystal Biotech, Inc. 136.75M
Arcutis Biotherapeutics, Inc. 253.18M